1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corporation

NMTC
NeuroOne Medical Technologies CorporationUS flagNASDAQ Capital Market
1.62
USD
-0.04
- -
14.10MMarket Cap

Total Valuation

NeuroOne Medical Technologies Corporation carries a market capitalization of 14.10M, placing it among publicly traded companies globally. Its enterprise value stands at 24.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap14.10M
Enterprise Value24.58M

Share Statistics

NeuroOne Medical Technologies Corporation currently has 8.70M shares outstanding.

Shares Outstanding8.70M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 2.73, and the price-to-book ratio stands at 7.02.

PE RatioN/A
PS Ratio2.73
PB Ratio7.02
P/TBV Ratio7.08
P/FCF Ratio-3.74
P/OCF Ratio-3.67

Enterprise Valuation

EV / Sales2.60
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

NeuroOne Medical Technologies Corporation maintains a current ratio of 2.84, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

Current Ratio2.84
Quick Ratio1.54
Debt / Equity4.65
Debt / EBITDA-0.02
Interest CoverageN/A

Financial Efficiency

Return on Equity (ROE)-124.66
Return on Assets (ROA)-87.56
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.01

Stock Price Statistics

NeuroOne Medical Technologies Corporation's stock has declined approximately -68.23529% over the past 52 weeks. The 50-day moving average sits at 2.12, while the 200-day moving average is 3.83.

Beta (5Y)N/A
52-Week Price Change-68.23529%
50-Day Moving Average2.12
200-Day Moving Average3.83
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, NeuroOne Medical Technologies Corporation generated 9.47M in revenue and converted that into -7.45M in net income, yielding earnings per share of -0.87. EBITDA reached -7.66M, while operating income came in at -7.90M.

Revenue9.47M
Gross Profit5.27M
Operating Income-7.90M
Pretax Income-7.45M
Net Income-7.45M
EBITDA-7.66M
EBIT-7.90M
Earnings Per Share (EPS)-0.87

Balance Sheet

NeuroOne Medical Technologies Corporation holds 2.05M in cash and equivalents against 175,345.00 in total debt, resulting in a net debt position of -2.05M. Total book value stands at 3.77M, with working capital of 3.75M providing operational flexibility.

Cash & Cash Equivalents2.05M
Total Debt175,345.00
Net Debt-2.05M
Equity (Book Value)3.77M
Book Value Per Share0.43
Working Capital3.75M

Cash Flow

NeuroOne Medical Technologies Corporation produced -7.05M in operating cash flow over the past twelve months. After subtracting -109,536.00 in capital expenditures, free cash flow totaled -7.16M - equivalent to -0.84 per share.

Operating Cash Flow-7.05M
Capital Expenditures-109,536.00
Free Cash Flow-7.16M
FCF Per Share-0.84

Margins

NeuroOne Medical Technologies Corporation operates with a gross margin of 55.65, reflecting its pricing power and cost economics. The operating margin of -83.43 and net profit margin of -78.63 provide insight into operational efficiency.

Gross Margin55.65
Operating Margin-83.43
Pretax Margin-78.63
Profit Margin-78.63
EBITDA Margin-80.93

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-4.42
FCF Yield-26.75

Stock Splits

NeuroOne Medical Technologies Corporation's most recent stock split took place on April 16, 2026 with a 6:1 split ratio.

Last Split Date4/16/2026
Split Ratio6:1

Scores

NeuroOne Medical Technologies Corporation posts an Altman Z-Score of -14.60, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-14.60